Phase 2 Myeloma Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You have been officially diagnosed with a blood cancer called multiple myeloma (MM)
• You have already received at least 4 different types of myeloma treatments, including specific drug types known as IMiDs, proteasome inhibitors, anti-CD38 therapy, and anti-BCMA therapy, across at least 3 separate rounds of treatment
• Your myeloma has gotten worse during or after your most recent treatment
• Tests during the screening period show signs of active, measurable myeloma in your body
• You are generally able to carry out normal daily activities with little or no difficulty (confirm with trial site for exact fitness level required)

Who may not be able to join:

• Your myeloma has spread to, or has a history of spreading to, your brain or spinal cord
• You currently have a serious active infection (such as a fungal, bacterial, or viral infection) that is not being controlled by treatment, or you have had a severe infection or blood infection in the last 28 days
• You have previously received a treatment that targets a specific protein called GPRC5D, or you have not waited long enough after your last myeloma treatment before joining the trial (confirm with trial site for exact waiting period required)
• There may be additional requirements not listed here that the trial team will check (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.